43 related articles for article (PubMed ID: 9637504)
1. Expression and characterization of recombinant soluble peptide: I-A complexes associated with murine experimental autoimmune diseases.
Radu CG; Ober BT; Colantonio L; Qadri A; Ward ES
J Immunol; 1998 Jun; 160(12):5915-21. PubMed ID: 9637504
[TBL] [Abstract][Full Text] [Related]
2. Single-chain MHC class II molecules induce T cell activation and apoptosis.
Rhode PR; Burkhardt M; Jiao J; Siddiqui AH; Huang GP; Wong HC
J Immunol; 1996 Dec; 157(11):4885-91. PubMed ID: 8943392
[TBL] [Abstract][Full Text] [Related]
3. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
[TBL] [Abstract][Full Text] [Related]
4. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of chicken major histocompatibility complex class II oligomers using a baculovirus expression system.
Niemiec PK; Read LR; Sharif S
Protein Expr Purif; 2006 Apr; 46(2):390-400. PubMed ID: 16236525
[TBL] [Abstract][Full Text] [Related]
6. The assembly and stability of MHC class II-(alpha beta)2 superdimers.
Schafer PH; Malapati S; Hanfelt KK; Pierce SK
J Immunol; 1998 Sep; 161(5):2307-16. PubMed ID: 9725225
[TBL] [Abstract][Full Text] [Related]
7. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity.
Chaves FA; Hou P; Wu S; Sant AJ
J Immunol Methods; 2005 May; 300(1-2):74-92. PubMed ID: 15896797
[TBL] [Abstract][Full Text] [Related]
9. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
Théry C; Brachet V; Regnault A; Rescigno M; Ricciardi-Castagnoli P; Bonnerot C; Amigorena S
J Immunol; 1998 Sep; 161(5):2106-13. PubMed ID: 9725201
[TBL] [Abstract][Full Text] [Related]
10. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera.
Casares S; Hurtado A; McEvoy RC; Sarukhan A; von Boehmer H; Brumeanu TD
Nat Immunol; 2002 Apr; 3(4):383-91. PubMed ID: 11862219
[TBL] [Abstract][Full Text] [Related]
13. Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses.
Lebowitz MS; O'Herrin SM; Hamad AR; Fahmy T; Marguet D; Barnes NC; Pardoll D; Bieler JG; Schneck JP
Cell Immunol; 1999 Mar; 192(2):175-84. PubMed ID: 10087186
[TBL] [Abstract][Full Text] [Related]
14. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
15. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
Wither JE; Vukusic B
J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
[TBL] [Abstract][Full Text] [Related]
16. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
[TBL] [Abstract][Full Text] [Related]
17. Kinetic isomers of a class II MHC-peptide complex.
Schmitt L; Boniface JJ; Davis MM; McConnell HM
Biochemistry; 1998 Dec; 37(50):17371-80. PubMed ID: 9860852
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
19. Probing molecular interactions within class II MHC Aq/glycopeptide/T-cell receptor complexes associated with collagen-induced arthritis.
Andersson IE; Dzhambazov B; Holmdahl R; Linusson A; Kihlberg J
J Med Chem; 2007 Nov; 50(23):5627-43. PubMed ID: 17944452
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterisation of functional early pregnancy factor expressed in Sf9 insect cells and in Escherichia coli.
Somodevilla-Torres MJ; Morton H; Zhang B; Reid S; Cavanagh AC
Protein Expr Purif; 2003 Dec; 32(2):276-87. PubMed ID: 14965774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
